{"product_id":"global-cancer-stem-cell-market-growth-status-and-outlook-2023-2029","title":"Global Cancer Stem Cell Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Cancer Stem Cell Market Growth (Status and Outlook) 2023-2029\u003cbr\u003e\nCancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Cancer Stem Cell Industry Forecast” looks at past sales and reviews total world Cancer Stem Cell sales in 2022, providing a comprehensive analysis by region and market sector of projected Cancer Stem Cell sales for 2023 through 2029. With Cancer Stem Cell sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Stem Cell industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Cancer Stem Cell landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Cancer Stem Cell portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Stem Cell market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Stem Cell and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Stem Cell.\u003c\/p\u003e\n\n\u003cp\u003eThe global Cancer Stem Cell market size is projected to grow from US$ 1033.3 million in 2022 to US$ 1758.9 million in 2029; it is expected to grow at a CAGR of 7.9% from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eNorth America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R\u0026amp;D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.\u003c\/p\u003e\n\n\u003cp\u003eAsia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R\u0026amp;D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Cancer Stem Cell market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nCell Culturing\u003cbr\u003e\nCell Separation\u003cbr\u003e\nCell Analysis\u003cbr\u003e\nMolecular Analysis\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nStem Cell Based Cancer Therapy\u003cbr\u003e\nTargeted CSCs\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nMexico\u003cbr\u003e\nBrazil\u003cbr\u003e\nAPAC\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nKorea\u003cbr\u003e\nSoutheast Asia\u003cbr\u003e\nIndia\u003cbr\u003e\nAustralia\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUK\u003cbr\u003e\nItaly\u003cbr\u003e\nRussia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\nEgypt\u003cbr\u003e\nSouth Africa\u003cbr\u003e\nIsrael\u003cbr\u003e\nTurkey\u003cbr\u003e\nGCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nThermo Fisher Scientific, Inc.\u003cbr\u003e\nAbbVie, Inc.\u003cbr\u003e\nMerck KGaA\u003cbr\u003e\nBionomics\u003cbr\u003e\nLonza\u003cbr\u003e\nStemline Therapeutics, Inc.\u003cbr\u003e\nMiltenyi Biotec\u003cbr\u003e\nPromoCell GmbH\u003cbr\u003e\nMacroGenics, Inc.\u003cbr\u003e\nOncoMed Pharmaceuticals, Inc.\u003cbr\u003e\nIrvine Scientific\u003cbr\u003e\nSTEMCELL Technologies Inc.\u003cbr\u003e\nSino Biological Inc.\u003cbr\u003e\nBIOTIME, Inc.\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 102 Pages \/ MCW16227542","offer_id":47645971710258,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true},{"title":"February, 2023 \/ 102 Pages \/ MCW16227543","offer_id":47645971743026,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-cancer-stem-cell-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}